SKAN Group AG (CH:SKAN)
:SKAN
Want to see CH:SKAN full AI Analyst Report?
SKAN Stock Chart & Stats
CHF54.50
CHF0.70(0.97%)
At close: 4:00 PM EST
CHF54.50
CHF0.70(0.97%)
Day’s Range― - ―
52-Week RangeCHF35.75 - CHF77.80
Previous CloseN/A
Volume1.93K
Average Volume (3M)22.50K
Market Cap
CHF1.16B
Enterprise ValueCHF1.15B
Total Cash (Recent Filing)CHF94.08M
Total Debt (Recent Filing)CHF131.47M
Price to Earnings (P/E)71.4
Beta0.96
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.77%
Share Statistics
EPS (TTM)0.72
Shares Outstanding22,483,524
10 Day Avg. Volume19,367
30 Day Avg. Volume22,504
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)10.37
Price to Sales (P/S)3.56
P/FCF Ratio56.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF62.50Price Target Upside14.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.36
Revenue Forecast (FY)CHF392.90M
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained gross margins near 70% indicate strong product-level pricing power and a differentiated, capital-equipment offering. That structural margin headroom supports funding R&D, service networks and bespoke project execution, insulating core profitability from moderate revenue swings.
Strong Revenue ReboundA 36% YoY revenue rebound reflects robust demand recovery in sterile pharma/biotech capex and successful project delivery. Durable industry investment in contamination control and growing installed base should sustain multi-year aftermarket and service revenue beyond individual project cycles.
Improved Cash GenerationMaterial improvement to operating cash flow and a return to positive free cash flow strengthen near-term liquidity and financial flexibility. That cash can fund lifecycle services, working capital and targeted investments without immediate equity raises, supporting execution of strategic initiatives.
Bears Say
Rising LeverageA sharp increase in leverage materially reduces balance-sheet flexibility and raises interest and covenant risk. With higher fixed obligations, the company is more exposed to profit volatility and may face constrained ability to invest or absorb project delays without prioritizing debt servicing.
Weakened ProfitabilityHalving of operating and net margins signals margin pressure from cost inflation, project mix or execution issues. Persistent margin deterioration would erode the firm's capacity to self-fund growth, weaken returns on capital and make meeting higher interest costs from added leverage harder over the medium term.
Volatile FCF ConversionLow and inconsistent conversion of earnings into free cash flow limits reliable funding for capex, services expansion and debt reduction. This volatility increases refinancing and operational risk, especially with the recent rise in leverage and lower margins constraining internal cash generation.
SKAN Group AG News
SKAN FAQ
What was SKAN Group AG’s price range in the past 12 months?
SKAN Group AG lowest stock price was CHF35.75 and its highest was CHF77.80 in the past 12 months.
What is SKAN Group AG’s market cap?
SKAN Group AG’s market cap is CHF1.16B.
When is SKAN Group AG’s upcoming earnings report date?
SKAN Group AG’s upcoming earnings report date is Aug 18, 2026 which is in 69 days.
How were SKAN Group AG’s earnings last quarter?
SKAN Group AG released its earnings results on Mar 24, 2026. The company reported CHF1.12 earnings per share for the quarter, beating the consensus estimate of CHF1 by CHF0.12.
Is SKAN Group AG overvalued?
According to Wall Street analysts SKAN Group AG’s price is currently Undervalued.
Does SKAN Group AG pay dividends?
SKAN Group AG pays a Annually dividend of CHF0.22 which represents an annual dividend yield of 0.77%. See more information on SKAN Group AG dividends here
What is SKAN Group AG’s EPS estimate?
SKAN Group AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SKAN Group AG have?
SKAN Group AG has 22,483,524 shares outstanding.
What happened to SKAN Group AG’s price movement after its last earnings report?
SKAN Group AG reported an EPS of CHF1.12 in its last earnings report, beating expectations of CHF1. Following the earnings report the stock price went down -3.535%.
Which hedge fund is a major shareholder of SKAN Group AG?
Currently, no hedge funds are holding shares in CH:SKAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SKAN Group AG
SKAN Group AG is a global leader specializing in critical solutions for the pharmaceutical and chemical sectors, offering advanced isolators, cleanroom technologies, and decontamination processes across Asia, Europe, and the Americas. The company operates through two distinct divisions: Equipment and Solutions (E&S), and Services and Consumables (S&C). Its E&S segment delivers essential products for pharmaceutical manufacturing, including high-tech isolators, integrated automated systems, aseptic filling solutions, and specialized laboratory and cleanroom equipment. Meanwhile, the S&C segment focuses on providing comprehensive life cycle support, ready-to-use consumables, and custom digital and client-specific solutions. Founded in 1968, the company, which changed its name from BV Holding AG to SKAN Group AG in October 2021, is headquartered in Allschwil, Switzerland.
SKAN Stock 12 Month Forecast
Average Price Target
CHF62.50
▲(14.68% Upside)
Technical Analysis
SFS Group AG
―
Straumann Holding AG
―
Tecan Group AG
―
Ypsomed Holding AG
―
COMET Holding AG
―
Options Prices
Currently, No data available
---